Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-16-082184
Filing Date
2016-02-16
Accepted
2016-02-16 11:38:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 v431753_424b3.htm 424B3 298394
2 GRAPHIC image_001.jpg GRAPHIC 2259
  Complete submission text file 0001144204-16-082184.txt   302674
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-196093 | Film No.: 161424967
SIC: 2834 Pharmaceutical Preparations